Esterase D enhances type I interferon signal transduction to suppress foot-and-mouth disease virus replication

Molecular Immunology

Volumn 75, Issue , 2016, Pages 112-121

  Li, Weiwei ^a   Zhu, Zixiang ^a   Cao, Weijun ^a   Yang, Fan ^a   Zhang, Xiangle ^a   Li, Dan ^a   Zhang, Keshan ^a   Li, Pengfei ^a   Mao, Ruoqing ^a   Liu, Xiangtao ^a   Zheng, Haixue ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Antiviral response; Esterase D; Foot and mouth disease virus; Interferon stimulated genes; IRF3

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON; CARBOXYLESTERASE; INTERFERON; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA; S-FORMYLGLUTATHIONE HYDROLASE; THIOL ESTER HYDROLASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SENDAI VIRUS; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS REPLICATION; ANIMAL; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PIG; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; INTERFERON TYPE I; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SWINE; THIOLESTER HYDROLASES; VIRUS REPLICATION;

EID: 84979300806     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2016.05.016     Document Type: Article

References (39)

1. Bamming, D., Horvath, C.M., Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2. J. Biol. Chem. 284 (2009), 9700–9712.
2. Belsham, G.J., McInerney, G.M., Ross-Smith, N., Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J. Virol. 74 (2000), 272–280.
3. Cashman, J.R., Perotti, B.Y., Berkman, C.E., Lin, J., Pharmacokinetics and molecular detoxication. Environ. Health Perspect. 104:Suppl. 1 (1996), 23–40.
4. de Los Santos, T., de Avila Botton, S., Weiblen, R., Grubman, M.J., The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80 (2006), 1906–1914.
5. Dias, C.C., Moraes, M.P., Segundo, F.D., de los Santos, T., Grubman, M.J., Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus. J. Interferon Cytokine Res. 31 (2011), 227–236.
6. Fan, W., Zhang, D., Qian, P., Qian, S., Wu, M., Chen, H., Li, X., Swine TRIM21 restricts FMDV infection via an intracellular neutralization mechanism. Antiviral Res. 127 (2016), 32–40.
7. Feng, Q., Hato, S.V., Langereis, M.A., Zoll, J., Virgen-Slane, R., Peisley, A., Hur, S., Semler, B.L., van Rij, R.P., van Kuppeveld, F.J., MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep. 2 (2012), 1187–1196.
8. Genin, P., Algarte, M., Roof, P., Lin, R.T., Hiscott, J., Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J. Immunol. 164 (2000), 5352–5361.
9. Gonzalez, C.F., Proudfoot, M., Brown, G., Korniyenko, Y., Mori, H., Savchenko, A.V., Yakunin, A.F., Molecular basis of formaldehyde detoxification. Characterization of two S-formylglutathione hydrolases from Escherichia coli, FrmB and YeiG. J. Biol. Chem. 281 (2006), 14514–14522.
10. Harms, N., Ras, J., Reijnders, W.N., van Spanning, R.J., Stouthamer, A.H., S-formylglutathione hydrolase of Paracoccus denitrificans is homologous to human esterase D: a universal pathway for formaldehyde detoxification?. J. Bacteriol. 178 (1996), 6296–6299.
11. Haydon, D.T., Kao, R.R., Kitching, R.P., The UK foot-and-mouth disease outbreak – the aftermath. Nat. Rev. Microbiol. 2 (2004), 675–681.
12. Higgs, R., Gabhann, J.N., Ben Larbi, N., Breen, E.P., Fitzgerald, K.A., Jefferies, C.A., The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 181 (2008), 1780–1786.
13. Husser, L., Alves, M.P., Ruggli, N., Summerfield, A., Identification of the role of RIG-I, MDA-5 and TLR3 in sensing RNA viruses in porcine epithelial cells using lentivirus-driven RNA interference. Virus Res. 159 (2011), 9–16.
14. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J., Takeuchi, O., Akira, S., IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6 (2005), 981–988.
15. Knight-Jones, T.J., Rushton, J., The economic impacts of foot and mouth disease – what are they, how big are they and where do they occur?. Prev. Vet. Med. 112 (2013), 161–173.
16. Kumar, H., Kawai, T., Akira, S., Pathogen recognition in the innate immune response. Biochem. J. 420 (2009), 1–16.
17. Lazear, H.M., Lancaster, A., Wilkins, C., Suthar, M.S., Huang, A., Vick, S.C., Clepper, L., Thackray, L., Brassil, M.M., Virgin, H.W., Nikolich-Zugich, J., Moses, A.V., Gale, M. Jr., Fruh, K., Diamond, M.S., IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog., 9, 2013, e1003118.
18. Li, D., Lei, C., Xu, Z., Yang, F., Liu, H., Zhu, Z., Li, S., Liu, X., Shu, H., Zheng, H., Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-β signaling pathway. Sci. Rep., 6, 2016, 21888.
19. Li, D., Yang, W., Yang, F., Liu, H., Zhu, Z., Lian, K., Lei, C., Li, S., Liu, X., Zheng, H., The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-β signaling pathway. FASEB J., 1, 2016 fj.15-281410.
20. Liu, X., Yao, M., Li, N., Wang, C., Zheng, Y., Cao, X., CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages. Blood 112 (2008), 4961–4970.
21. Mason, P.W., Grubman, M.J., Baxt, B., Molecular basis of pathogenesis of FMDV. Virus Res. 91 (2003), 9–32.
22. Matsumiya, T., Stafforini, D.M., Function and regulation of retinoic acid-inducible gene-I. Crit. Rev. Immunol. 30 (2010), 489–513.
23. Megyeri, K., Au, W.-C., Rosztoczy, I., Raj, N., Miller, R.L., Tomai, M.A., Pitha, P.M., Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways. Mol. Cell. Biol. 15 (1995), 2207–2218.
24. Moraes, M.P., de Los Santos, T., Koster, M., Turecek, T., Wang, H., Andreyev, V.G., Grubman, M.J., Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol. 81 (2007), 7124–7135.
25. Okunuki, Y., Usui, Y., Kezuka, T., Hattori, T., Masuko, K., Nakamura, H., Yudoh, K., Goto, H., Usui, M., Nishioka, K., Kato, T., Takeuchi, M., Proteomic surveillance of retinal autoantigens in endogenous uveitis: implication of esterase D and brain-type creatine kinase as novel autoantigens. Mol. Vis. 14 (2008), 1094–1104.
26. Panne, D., McWhirter, S.M., Maniatis, T., Harrison, S.C., Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J. Biol. Chem. 282 (2007), 22816–22822.
27. Platanias, L.C., Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5 (2005), 375–386.
28. Pythoud, C., Rodrigo, W.W., Pasqual, G., Rothenberger, S., Martinez-Sobrido, L., de la Torre, J.C., Kunz, S., Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon. J. Virol. 86 (2012), 7728–7738.
29. Schoggins, J.W., Rice, C.M., Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1 (2011), 519–525.
30. Sun, L., Liu, S., Chen, Z.J., SnapShot: pathways of antiviral innate immunity. Cell, 140, 2010 436-436 e432.
31. Sun, X.X., Wang, Y.G., Xirodimas, D.P., Dai, M.S., Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation. J. Biol. Chem. 285 (2010), 25812–25821.
32. Wang, D., Fang, L., Luo, R., Ye, R., Fang, Y., Xie, L., Chen, H., Xiao, S., Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem. Biophys. Res. Commun. 399 (2010), 72–78.
33. Wiedl, T., Arni, S., Roschitzki, B., Grossmann, J., Collaud, S., Soltermann, A., Hillinger, S., Aebersold, R., Weder, W., Activity-based proteomics: identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma. J. Proteomics 74 (2011), 1884–1894.
34. Xu, J., Qian, P., Wu, Q., Liu, S., Fan, W., Zhang, K., Wang, R., Zhang, H., Chen, H., Li, X., Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo. Antiviral Res. 109 (2014), 22–29.
35. Yu, Y.X., Hayward, G.S., The ubiquitin E3 ligase RAUL negatively regulates type I interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 33 (2010), 863–877.
36. Zhang, D.X., Zhang, D.E., Interferon-Stimulated gene 15 and the protein ISGylation system. J. Interf. Cytok. Res. 31 (2011), 119–130.
37. Zheng, H., Guo, J., Jin, Y., Yang, F., He, J., Lv, L., Zhang, K., Wu, Q., Liu, X., Cai, X., Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development. PLoS One, 8, 2013, e55228.
38. Zhou, Q., Lin, H., Wang, S., Wang, S., Ran, Y., Liu, Y., Ye, W., Xiong, X., Zhong, B., Shu, H.B., Wang, Y.Y., The ER-associated protein ZDHHC1 is a positive regulator of DNA virus-triggered, MITA/STING-dependent innate immune signaling. Cell Host Microbe 16 (2014), 450–461.
39. Zhu, Z., Yang, Y., Wei, J., Shao, D., Shi, Z., Li, B., Liu, K., Qiu, Y., Zheng, H., Ma, Z., Type I interferon-mediated immune response against influenza A virus is attenuated in the absence of p53. Biochem. Biophys. Res. Commun. 454 (2014), 189–195.